| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |